Please click here to obtain permission to reproduce this image.
Click on image to view larger version.

Figure 4 Leading-edge voltage (top) and delivered energy (bottom) for effective shocks in patients with paroxysmal or persistent atrial fibrillation (AF) at baseline and after flecainide administration.
|